52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jan Tack, Professor
Department of Gastroenterology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium
Study Chair - Lin Chang, Professor
Digestive Health and Nutrition Clinic. University of California, Los Angeles, CA, USA
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
139 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Hradec Králové, Czechia
- Facility name not stated
Kralove, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Příbram, Czechia
- Facility name not stated
Slaný, Czechia
- Facility name not stated
Zlín, Czechia
- Facility name not stated
České Budějovice, Czechia
- Facility name not stated
Berlin, Germany
- Facility name not stated
Berlin, Germany
- Facility name not stated
Bochum, Germany
- Facility name not stated
Frankfurt, Germany
- Facility name not stated
Hamburg, Germany
- Facility name not stated
Hanover, Germany
- Facility name not stated
Karlsruhe, Germany
- Facility name not stated
Leipzig, Germany
- Facility name not stated
Mainz, Germany
- Facility name not stated
Schwerin, Germany
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Debrecen, Hungary
- Facility name not stated
Debrecen, Hungary
- Facility name not stated
Gyula, Hungary
- Facility name not stated
Mátészalka, Hungary
- Facility name not stated
Pécs, Hungary
- Facility name not stated
Szekszárd, Hungary
- Facility name not stated
Vác, Hungary
- Facility name not stated
Daugavpils, Latvia
- Facility name not stated
Riga, Latvia
- Facility name not stated
Riga, Latvia
- Facility name not stated
Riga III, Latvia
- Facility name not stated
Valmiera, Latvia
- Facility name not stated
Katowice, Poland
- Facility name not stated
Lodz, Poland
- Facility name not stated
Poznan, Poland
- Facility name not stated
Poznan, Poland
- Facility name not stated
Sopot, Poland
- Facility name not stated
Staszów, Poland
- Facility name not stated
Warsaw, Poland
- Facility name not stated
Warsaw, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2014
- Primary completion
- 30 Nov 2015
- Completion
- 30 Nov 2015
- Last update posted
- 3 Mar 2017
- Registered enrollment
- 558
- Registry id
- NCT02120027
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.